Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. Today I’m going to look at history repeating between Gilead Sciences and Merck & Co. I’m hoping history has ended in at least one branch of the Apple-Samsung litigation. Meanwhile, copyright Zelig Stephen Doniger makes a cameo in two other items. 

As always, email me tips on anything IP and find me on Twitter @scottkgraham.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]